Gilmore Neil O'Neill Sarepta Therapeutics, Inc. (SRPT) insider trading activity

SRPT Quotes by TradingView

Gilmore Neil O'Neill is EVP, R&D & CMO of Sarepta Therapeutics, Inc.. Currently has a direct ownership of 29,070 shares of SRPT, which is worth approximately $3.79 Million. The most recent transaction as insider was on Mar 03, 2021, when has been sold 15,000 shares (Common Stock) at a price of $0.0 per share, resulting in proceeds of $0. This information was disclosed in a Form 4 filing with the Securities and Exchange Commission (SEC).

Shares Held (Direct Ownership) 29.1K
0% 3M change
0% 12M change
Total Value Held $3.79 Million

Gilmore Neil O'Neill Transaction History

Date Transaction Value Shares Traded Shares Held Form
Mar 03 2021
BUY
Grant, award, or other acquisition
-
15,000 Added 34.04%
29,070 Common Stock

Also insider at

UBX
Unity Biotechnology, Inc. Healthcare
APTX
Aptinyx Inc. Healthcare
EDIT
Editas Medicine, Inc. Healthcare
CEO
GNO

Gilmore Neil O'Neill

EVP, R&D & CMO
Cambridge, MA

Track Institutional and Insider Activities on SRPT

Follow Sarepta Therapeutics, Inc. and customize your updates to receive the information that matters most to you.

Institutional Portfolio Updates

Receive a notification when an Institution or Guru buys or sells SRPT shares.

Notify only if

Insider Trading

Get notified when an Sarepta Therapeutics, Inc. insider buys or sells SRPT shares.

Notify only if

News

Receive news related to Sarepta Therapeutics, Inc.

Choose your preferred platform and Sign Up 👇 Telegram Email
Track Activities on SRPT